JPH0446928B2 - - Google Patents

Info

Publication number
JPH0446928B2
JPH0446928B2 JP56112914A JP11291481A JPH0446928B2 JP H0446928 B2 JPH0446928 B2 JP H0446928B2 JP 56112914 A JP56112914 A JP 56112914A JP 11291481 A JP11291481 A JP 11291481A JP H0446928 B2 JPH0446928 B2 JP H0446928B2
Authority
JP
Japan
Prior art keywords
lymphotoxin
cells
human
animal
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP56112914A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5815921A (ja
Inventor
Haruo Oonishi
Masakazu Mihashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Mochida Pharmaceutical Co Ltd
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Mochida Pharmaceutical Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Priority to JP56112914A priority Critical patent/JPS5815921A/ja
Priority to FR8212541A priority patent/FR2513124B1/fr
Priority to SE8204382A priority patent/SE8204382L/xx
Priority to AU86200/82A priority patent/AU560793B2/en
Priority to CH4420/82A priority patent/CH664974A5/fr
Priority to KR8203215A priority patent/KR870001433B1/ko
Priority to IT48855/82A priority patent/IT1196549B/it
Priority to DE3249946A priority patent/DE3249946C2/de
Priority to AT0283582A priority patent/AT387980B/de
Priority to DE3227262A priority patent/DE3227262C3/de
Priority to ES514210A priority patent/ES514210A0/es
Priority to US06/400,487 priority patent/US4495282A/en
Priority to GB08221100A priority patent/GB2106117B/en
Publication of JPS5815921A publication Critical patent/JPS5815921A/ja
Priority to SE9000532A priority patent/SE9000532L/xx
Publication of JPH0446928B2 publication Critical patent/JPH0446928B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP56112914A 1981-07-21 1981-07-21 抗リンホトキシン感受性疾患剤 Granted JPS5815921A (ja)

Priority Applications (14)

Application Number Priority Date Filing Date Title
JP56112914A JPS5815921A (ja) 1981-07-21 1981-07-21 抗リンホトキシン感受性疾患剤
FR8212541A FR2513124B1 (fr) 1981-07-21 1982-07-19 Production et applications du facteur de lyse des cellules-cibles
SE8204382A SE8204382L (sv) 1981-07-21 1982-07-19 Sett att framstella malcellysfaktor och anvendning derav
AU86200/82A AU560793B2 (en) 1981-07-21 1982-07-20 Production of target cell lysis factor
CH4420/82A CH664974A5 (fr) 1981-07-21 1982-07-20 Production du facteur de lyse des cellules-cibles.
KR8203215A KR870001433B1 (ko) 1981-07-21 1982-07-20 적상적혈구(的狀赤血球) 붕괴인자의 제조 방법
IT48855/82A IT1196549B (it) 1981-07-21 1982-07-20 Procedimento per la produzione del fattore di lisi cellule bersaglio (tclf),prodotto ottenuto a suo impiego in terapia clinica,in particolare come agente citolitico antitumurale
DE3249946A DE3249946C2 (de) 1981-07-21 1982-07-21 hTNF-haltiges therapeutisches Mittel gegen maligne Tumoren und dessen Verwendung
AT0283582A AT387980B (de) 1981-07-21 1982-07-21 Verfahren zur herstellung eines die aufloesung menschlicher zellen bewirkenden faktors
DE3227262A DE3227262C3 (de) 1981-07-21 1982-07-21 Verfahren zur Herstellung von menschlichem Tumor-Nekrose-Faktor und menschlicher Tumor-Nekrose-Faktor
ES514210A ES514210A0 (es) 1981-07-21 1982-07-21 Un procedimiento para la produccion de tclf.
US06/400,487 US4495282A (en) 1981-07-21 1982-07-21 Process for producing target cell lysis factor and uses therewith
GB08221100A GB2106117B (en) 1981-07-21 1982-07-21 Process for producing target cell lysis factor
SE9000532A SE9000532L (sv) 1981-07-21 1990-02-14 Farmaceutisk tclf-komposition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56112914A JPS5815921A (ja) 1981-07-21 1981-07-21 抗リンホトキシン感受性疾患剤

Publications (2)

Publication Number Publication Date
JPS5815921A JPS5815921A (ja) 1983-01-29
JPH0446928B2 true JPH0446928B2 (enrdf_load_stackoverflow) 1992-07-31

Family

ID=14598641

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56112914A Granted JPS5815921A (ja) 1981-07-21 1981-07-21 抗リンホトキシン感受性疾患剤

Country Status (1)

Country Link
JP (1) JPS5815921A (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5889195A (ja) * 1981-11-21 1983-05-27 Hayashibara Biochem Lab Inc 標的細胞障害性因子の製造方法
JPH0764744B2 (ja) * 1981-11-21 1995-07-12 株式会社林原生物化学研究所 標的細胞障害性因子とヒトインタ−フェロンとを有効成分として含有する悪性腫瘍治療剤

Also Published As

Publication number Publication date
JPS5815921A (ja) 1983-01-29

Similar Documents

Publication Publication Date Title
NL192086C (nl) Werkwijze ter bereiding van interferonen en werkwijze ter bereiding van een geneesmiddel dat interferonen bevat.
US4495282A (en) Process for producing target cell lysis factor and uses therewith
US4621050A (en) Process for the production of human colony-stimulating factor
JPS631296B2 (enrdf_load_stackoverflow)
KR930000188B1 (ko) 신규 림포카인(lymphokine), 이 림포카인에 특이적인 모노클로날 항체 및 이들의 제조방법
JPS6227048B2 (enrdf_load_stackoverflow)
KR930004596B1 (ko) 신규 림포킨(lymphokine) 및 이에 대해 특이성을 갖는 모노클로날(monoclonal) 항체의 제조 방법
JPS58107197A (ja) ツモアネクロシスフアクタ−の製造方法
JPH0446928B2 (enrdf_load_stackoverflow)
JPH0214039B2 (enrdf_load_stackoverflow)
JPS5821621A (ja) ヒトツモア・ネクロシス・ファクタ−を含有する悪性腫瘍治療剤
JP2926409B2 (ja) 癌転移抑制因子の製造方法
KR950008569B1 (ko) 신규 림포카인(lymphokine) 및 그 제조방법과 사용방법
JPS5888322A (ja) 標的細胞障害性因子を含有する悪性腫瘍治療剤とその製造方法
JP2532025B2 (ja) 新リンホカインｉｉｉを有効成分とする抗腫瘍作用を有するリンホカインの活性増強剤
KR970002165B1 (ko) γ-인터페론의 제조방법과 그 용도
JP2518634B2 (ja) ヒト ツモア・ネクロシス・フアクタ−の製造方法
JP2518635B2 (ja) ヒト ツモア・ネクロシス・フアクタ−
JP2850293B2 (ja) γ−インターフェロン感受性疾患剤
KR830001817B1 (ko) 타이프ⅱ 인터페론의 제조방법
JPH0527640B2 (enrdf_load_stackoverflow)
KR820001174B1 (ko) 사람 특이성 인터페론의 제조법
JPH0523755B2 (enrdf_load_stackoverflow)
JPS61115027A (ja) 新リンホカイン２とその製法および用途
JPS5889195A (ja) 標的細胞障害性因子の製造方法